Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population

Colorectal cancer is a type of oncopathology widespread in Kazakhstan. The genetic component, as well as the possible etiopathogenetic mechanisms, is widely studied. One of the most promising areas is the study of diagnostic and prognostic possibilities of inflammatory biomarkers in patients with di...

Full description

Saved in:
Bibliographic Details
Main Authors: L. Akhmaltdinova, V. Sirota, V. Zhumaliyeva, D. Babenko, I. Kadyrova, Z. Tauesheva, D. Taizhanova, A. Ibraeva, M. Maratkyzy, A. Turmukhambetova
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:International Journal of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/9476326
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546933100511232
author L. Akhmaltdinova
V. Sirota
V. Zhumaliyeva
D. Babenko
I. Kadyrova
Z. Tauesheva
D. Taizhanova
A. Ibraeva
M. Maratkyzy
A. Turmukhambetova
author_facet L. Akhmaltdinova
V. Sirota
V. Zhumaliyeva
D. Babenko
I. Kadyrova
Z. Tauesheva
D. Taizhanova
A. Ibraeva
M. Maratkyzy
A. Turmukhambetova
author_sort L. Akhmaltdinova
collection DOAJ
description Colorectal cancer is a type of oncopathology widespread in Kazakhstan. The genetic component, as well as the possible etiopathogenetic mechanisms, is widely studied. One of the most promising areas is the study of diagnostic and prognostic possibilities of inflammatory biomarkers in patients with different degrees of tumor differentiation. The following biomarkers were included in the study panel: stem cell factor (SCF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF2), interleukin 6 (IL6), interleukin 8 (IL8), macrophage migration inhibitory factor (MIF), soluble Fas (SFAS), soluble Fas ligand (sFASL), transforming growth factor β (TGF), tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand (TRAIL), and programmed death ligand 1 (PD-L1). The data of our study show that most of the basic proinflammatory cytokines are involved in the systemic process and their levels do not depend on the level of tissue differentiation. Serum PD-L1 has shown itself to be a promising marker for tumor growth, which depends on the degree of differentiation.
format Article
id doaj-art-3836a86b3bd245bd930fb9396c5522d1
institution Kabale University
issn 2090-8040
2042-0099
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series International Journal of Inflammation
spelling doaj-art-3836a86b3bd245bd930fb9396c5522d12025-02-03T06:46:38ZengWileyInternational Journal of Inflammation2090-80402042-00992020-01-01202010.1155/2020/94763269476326Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan PopulationL. Akhmaltdinova0V. Sirota1V. Zhumaliyeva2D. Babenko3I. Kadyrova4Z. Tauesheva5D. Taizhanova6A. Ibraeva7M. Maratkyzy8A. Turmukhambetova9Shared Resource Lab of the Karaganda Medical University, Karaganda 10001, KazakhstanOncology Department of the Karaganda Medical University, Karaganda 10001, KazakhstanOncology Department of the Karaganda Medical University, Karaganda 10001, KazakhstanShared Resource Lab of the Karaganda Medical University, Karaganda 10001, KazakhstanShared Resource Lab of the Karaganda Medical University, Karaganda 10001, KazakhstanDepartment of Internal Diseases of the Karaganda Medical University, Karaganda 10001, KazakhstanDepartment of Internal Diseases of the Karaganda Medical University, Karaganda 10001, KazakhstanShared Resource Lab of the Karaganda Medical University, Karaganda 10001, KazakhstanShared Resource Lab of the Karaganda Medical University, Karaganda 10001, KazakhstanScience and Strategic Development Department of the Karaganda Medical University, Karaganda 10001, KazakhstanColorectal cancer is a type of oncopathology widespread in Kazakhstan. The genetic component, as well as the possible etiopathogenetic mechanisms, is widely studied. One of the most promising areas is the study of diagnostic and prognostic possibilities of inflammatory biomarkers in patients with different degrees of tumor differentiation. The following biomarkers were included in the study panel: stem cell factor (SCF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF2), interleukin 6 (IL6), interleukin 8 (IL8), macrophage migration inhibitory factor (MIF), soluble Fas (SFAS), soluble Fas ligand (sFASL), transforming growth factor β (TGF), tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand (TRAIL), and programmed death ligand 1 (PD-L1). The data of our study show that most of the basic proinflammatory cytokines are involved in the systemic process and their levels do not depend on the level of tissue differentiation. Serum PD-L1 has shown itself to be a promising marker for tumor growth, which depends on the degree of differentiation.http://dx.doi.org/10.1155/2020/9476326
spellingShingle L. Akhmaltdinova
V. Sirota
V. Zhumaliyeva
D. Babenko
I. Kadyrova
Z. Tauesheva
D. Taizhanova
A. Ibraeva
M. Maratkyzy
A. Turmukhambetova
Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
International Journal of Inflammation
title Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
title_full Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
title_fullStr Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
title_full_unstemmed Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
title_short Inflammatory Serum Biomarkers in Colorectal Cancer in Kazakhstan Population
title_sort inflammatory serum biomarkers in colorectal cancer in kazakhstan population
url http://dx.doi.org/10.1155/2020/9476326
work_keys_str_mv AT lakhmaltdinova inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT vsirota inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT vzhumaliyeva inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT dbabenko inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT ikadyrova inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT ztauesheva inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT dtaizhanova inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT aibraeva inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT mmaratkyzy inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation
AT aturmukhambetova inflammatoryserumbiomarkersincolorectalcancerinkazakhstanpopulation